• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度南部一家三级医疗中心对尿路感染的回顾性分析,特别提及对磷霉素耐药大肠埃希菌分离株的表型和基因型检测

A Retrospective Analysis of Urinary Tract Infections With Special Reference to the Phenotypic and Genotypic Detection of Fosfomycin-Resistant Escherichia coli Isolates at a Tertiary Care Center in South India.

作者信息

M Vasuki, Jacob Eunice Swarna, Sivagamasundari P, Kumar P B Praveen

机构信息

Department of Microbiology, Thanjavur Medical College, Thanjavur, IND.

出版信息

Cureus. 2025 Jul 5;17(7):e87359. doi: 10.7759/cureus.87359. eCollection 2025 Jul.

DOI:10.7759/cureus.87359
PMID:40765608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12322509/
Abstract

One of the leading causes of morbidity worldwide is urinary tract infections (UTIs). We are already running out of antimicrobial drugs in this era of antimicrobial resistance. It is important to know the antimicrobial resistance pattern of all organisms that commonly cause human diseases. The purpose of this investigation was to identify the pathogen that causes UTIs and to characterize the molecular makeup of the isolate of that is resistant to fosfomycin in urine samples. A total of 1104 samples were examined during the June-August 2024 retrospective investigation at our institution. However, only 91 isolates of were detected using standard microbiological methods. The Kirby-Bauer disk diffusion method was used to assess their susceptibility to antimicrobials. Of the 91 recovered , 97% (n = 88) exhibited phenotypic susceptibility to fosfomycin, while the remaining 3 fosfomycin-resistant isolates underwent real-time polymerase chain reaction (RT-PCR). However, the fosA3 gene was detected in only one fosfomycin-resistant isolate. While urinary tract infections are a common and widespread ailment that affects a large number of people worldwide, antibiotics are currently limited in their ability to treat them. Hence, fosfomycin may be the preferred choice of antibiotic.

摘要

全球发病的主要原因之一是尿路感染(UTIs)。在这个抗菌药物耐药的时代,我们的抗菌药物已经快用完了。了解所有常见的引起人类疾病的生物体的抗菌药物耐药模式很重要。本研究的目的是确定引起尿路感染的病原体,并对尿液样本中对磷霉素耐药的分离株的分子组成进行表征。在我们机构于2024年6月至8月进行的回顾性调查中,共检查了1104份样本。然而,使用标准微生物学方法仅检测到91株分离株。采用 Kirby-Bauer 纸片扩散法评估它们对抗菌药物的敏感性。在回收的91株分离株中,97%(n = 88)对磷霉素表现出表型敏感性,而其余3株对磷霉素耐药的分离株进行了实时聚合酶链反应(RT-PCR)。然而,仅在一株对磷霉素耐药的分离株中检测到fosA3基因。虽然尿路感染是一种常见且广泛的疾病,影响着全球大量人群,但目前抗生素治疗尿路感染的能力有限。因此,磷霉素可能是抗生素的首选。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9200/12322509/a9aea5b186f6/cureus-0017-00000087359-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9200/12322509/ce652d312b02/cureus-0017-00000087359-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9200/12322509/db291a80dada/cureus-0017-00000087359-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9200/12322509/bde49ee11713/cureus-0017-00000087359-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9200/12322509/a9aea5b186f6/cureus-0017-00000087359-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9200/12322509/ce652d312b02/cureus-0017-00000087359-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9200/12322509/db291a80dada/cureus-0017-00000087359-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9200/12322509/bde49ee11713/cureus-0017-00000087359-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9200/12322509/a9aea5b186f6/cureus-0017-00000087359-i04.jpg

相似文献

1
A Retrospective Analysis of Urinary Tract Infections With Special Reference to the Phenotypic and Genotypic Detection of Fosfomycin-Resistant Escherichia coli Isolates at a Tertiary Care Center in South India.印度南部一家三级医疗中心对尿路感染的回顾性分析,特别提及对磷霉素耐药大肠埃希菌分离株的表型和基因型检测
Cureus. 2025 Jul 5;17(7):e87359. doi: 10.7759/cureus.87359. eCollection 2025 Jul.
2
Fosfomycin resistance in extended-spectrum beta-lactamase producing isolated from urinary tract-infected patients in a tertiary care hospital.在一家三级护理医院中,从尿路感染患者分离出的产超广谱β-内酰胺酶菌株中的磷霉素耐药性。
J Med Microbiol. 2025 Jul;74(7). doi: 10.1099/jmm.0.002039.
3
The prevalence and susceptibility patterns of uropathogens in a private teaching hospital: A six years retrospective study at GAMBY teaching hospital, Bahir Dar, Ethiopia.一家私立教学医院尿路病原体的流行情况及药敏模式:埃塞俄比亚巴赫达尔甘比教学医院的六年回顾性研究
Urologia. 2025 Aug;92(3):493-502. doi: 10.1177/03915603251316700. Epub 2025 Feb 20.
4
Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model.用于减少抗菌药物耐药性的尿路感染即时检测:一项系统评价和概念性经济模型
Health Technol Assess. 2024 Nov;28(77):1-109. doi: 10.3310/PTMV8524.
5
Bacterial profile and antimicrobial susceptibility pattern of urinary tract infection among diabetic patients at Bule Hora University Teaching Hospital, Southern Ethiopia.埃塞俄比亚南部布勒霍拉大学教学医院糖尿病患者尿路感染的细菌谱及抗菌药物敏感性模式
Sci Rep. 2025 Jul 6;15(1):24112. doi: 10.1038/s41598-025-05782-8.
6
Multiple antibiotic resistance indexing and molecular identification of isolated from clinical and nonclinical sources in Port Harcourt Metropolis, Nigeria.尼日利亚哈科特港大都市临床和非临床来源分离菌的多重抗生素耐药性指数测定及分子鉴定
Pan Afr Med J. 2025 May 13;51:11. doi: 10.11604/pamj.2025.51.11.38524. eCollection 2025.
7
Probiotics for preventing urinary tract infection in people with neuropathic bladder.益生菌用于预防神经源性膀胱患者的尿路感染
Cochrane Database Syst Rev. 2017 Sep 8;9(9):CD010723. doi: 10.1002/14651858.CD010723.pub2.
8
Urinary tract infection, bacteremia and Non-Typhoidal Salmonella gastroenteritis in Algeria: First report of Salmonella case isolated from urine in Algeria at Ben badis constantine hospital.阿尔及利亚的尿路感染、菌血症和非伤寒沙门氏菌肠胃炎:在贝尼巴迪斯君士坦丁医院首次报告阿尔及利亚从尿液中分离出的沙门氏菌病例。
Microb Pathog. 2025 Oct;207:107897. doi: 10.1016/j.micpath.2025.107897. Epub 2025 Jul 22.
9
D-mannose for preventing and treating urinary tract infections.D-甘露糖防治尿路感染。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD013608. doi: 10.1002/14651858.CD013608.pub2.
10
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.

本文引用的文献

1
Comprehensive insights into UTIs: from pathophysiology to precision diagnosis and management.全面了解尿路感染:从病理生理学到精准诊断与管理。
Front Cell Infect Microbiol. 2024 Sep 24;14:1402941. doi: 10.3389/fcimb.2024.1402941. eCollection 2024.
2
Prevalence of Fosfomycin Resistance Among Enterobacterales Isolates in A Tertiary Care Hospital from Turkey.土耳其一家三级护理医院中分离出的肠杆菌科细菌对磷霉素的耐药率
Infect Dis Clin Microbiol. 2022 Dec 21;4(4):252-257. doi: 10.36519/idcm.2022.163. eCollection 2022 Dec.
3
Urinary Tract Infections: Core Curriculum 2024.
尿路感染:2024 年核心课程。
Am J Kidney Dis. 2024 Jan;83(1):90-100. doi: 10.1053/j.ajkd.2023.08.009. Epub 2023 Oct 30.
4
Fosfomycin resistance mechanisms in : an increasing threat.磷霉素耐药机制:日益严峻的威胁。
Front Cell Infect Microbiol. 2023 Jul 4;13:1178547. doi: 10.3389/fcimb.2023.1178547. eCollection 2023.
5
Antibiotic susceptibility and fosfomycin resistance characterization in a cohort of children older than 6 years of age with urinary tract infection.在一组年龄大于 6 岁的尿路感染患儿中,对其进行抗生素敏感性和磷霉素耐药性特征分析。
Rev Argent Microbiol. 2022 Apr-Jun;54(2):120-124. doi: 10.1016/j.ram.2021.04.002. Epub 2021 Jun 19.
6
Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from Australia.鉴定和特征分析澳大利亚大肠埃希菌尿路感染分离株中的磷霉素耐药性。
Int J Antimicrob Agents. 2020 Oct;56(4):106121. doi: 10.1016/j.ijantimicag.2020.106121. Epub 2020 Jul 31.
7
Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?单纯性尿路感染中口服抗菌药物的敏感性模式:磷霉素是否仍然有效?
J Family Med Prim Care. 2020 Feb 28;9(2):850-853. doi: 10.4103/jfmpc.jfmpc_970_19. eCollection 2020 Feb.
8
Fosfomycin: Mechanism and Resistance.磷霉素:作用机制与耐药性
Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a025262. doi: 10.1101/cshperspect.a025262.